Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency

BACKGROUND: Dual-release hydrocortisone (DR-HC) improves metabolism in patients with adrenal insufficiency. The aims of this study were to compare the cardiovascular and metabolic effects of conventional glucocorticoids (GCs) vs. DR-HC and of high vs. low doses of GCs, after 48 months of observation...

Descripción completa

Detalles Bibliográficos
Autores principales: Guarnotta, V, Di Stefano, C, Santoro, A, Ciresi, A, Coppola, A, Giordano, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599082/
https://www.ncbi.nlm.nih.gov/pubmed/31252397
http://dx.doi.org/10.1530/EC-19-0176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599082/
https://www.ncbi.nlm.nih.gov/pubmed/31252397
http://dx.doi.org/10.1530/EC-19-0176

Ejemplares similares